Mechanism of Action
Berberine acts primarily on cellular energy metabolism. After intestinal absorption, it influences the signaling pathways that regulate glucose utilization by tissues. In practical terms, it promotes glucose transport from the bloodstream into muscle and liver cells, thereby reducing circulating blood sugar. Simultaneously, berberine modulates fat metabolism by slowing hepatic synthesis of cholesterol and triglycerides. It also supports the catabolic phase of cellular renewal (autophagy, a process of recycling damaged components). This action on cellular housekeeping is documented in the longevity literature, where the alternation between anabolic and catabolic phases is considered protective.
Key Benefits
- Strong
Meta-analyses of randomized controlled trials show a significant reduction in fasting blood glucose and glycated hemoglobin in adults with disrupted carbohydrate metabolism, with magnitudes comparable to certain reference molecules.
- Strong
Several controlled trials document a reduction in total cholesterol, LDL cholesterol, and triglycerides following berberine supplementation over periods of 8 to 24 weeks.
- Moderate
A meta-analysis pooling over 2,000 participants highlights a favorable effect on body weight and waist circumference in overweight subjects.
- Moderate
Clinical trials show improved insulin sensitivity, measured by the HOMA-IR index, after 12 weeks of supplementation.
- Moderate
Clinical research documents support for digestive comfort and gut microbiota balance, with modulation of bacterial diversity observed in several controlled studies.
- Emerging
Preliminary human data suggest support for cellular renewal through the autophagy pathway, an active research axis in aging biology.
Dosage & Forms
Several forms of berberine exist on the market: berberine hydrochloride (the classic form), berberine phytosome (complexed with phospholipids), and dihydroberberine (a reduced metabolite with increased absorption). Hydrochloride remains the most studied form in clinical trials, with the majority of available safety and efficacy data. The oral bioavailability of free berberine is naturally low (less than 5%). Extracts standardized in hydrochloride, obtained through concentrated extraction (approximately 50:1 ratio from barberry root), achieve relevant plasma concentrations. Dosages studied in clinical trials generally range from 500 to 1,500 mg per day, divided into two to three doses taken with meals to optimize absorption and limit digestive discomfort. Singular selects berberine hydrochloride extracted from Berberis vulgaris for its robust clinical profile and documented track record.
In the Singular Formula
Inclusion rationale
Isoquinoline alkaloid with an intense yellow pigment, naturally found in barberry (Berberis vulgaris), goldenseal and coptis. Used for millennia in Chinese and Ayurvedic herbal traditions, berberine is today one of the most studied plant compounds in the world, with over 5,000 referenced scientific publications. Its primary mechanism rests on the regulation of cellular energy metabolism. Berberine modulates glycemic balance by acting on pathways that govern how cells use glucose and lipids. Meta-analyses of randomized controlled trials have demonstrated a significant reduction in fasting blood glucose and glycated hemoglobin in participants with disrupted carbohydrate metabolism, with magnitudes comparable to certain reference molecules. Research also documents reductions in total cholesterol and triglycerides in several controlled trials. Its naturally limited oral bioavailability (less than 5% in free form) has led to the development of optimized forms. Extracts standardized in berberine hydrochloride, combined with enhanced absorption technologies, achieve relevant plasma concentrations. The safety profile is well documented at supplementation doses, with a track record of human use spanning several decades.
Selected form
Plant alkaloid extracted from barberry root (Berberis vulgaris), through hydroethanolic extraction with a concentrated ratio of approximately 50:1. This highly purified form as berberine hydrochloride is obtained without preservatives or residual solvents. Extraction from the root, the part richest in berberine, ensures an optimal alkaloid profile. Quality: vegan, non-GMO, pesticide-free, allergen-free, preservative-free, residual solvent-free, Halal and Kosher certified.
Formula dosage
0 to 380 mg.
Synergies in the formula
Safety & Precautions
Berberine's safety profile is documented through several decades of human use and numerous controlled trials. At common supplementation doses (500 to 1,500 mg/day), reported adverse effects are primarily digestive (gastric discomfort, transient diarrhea) and generally resolve with gradual introduction. Splitting the dose across meals reduces this discomfort. Berberine may interact with certain compounds metabolized through the same hepatic pathways. Individuals using hypoglycemic or lipid-lowering molecules should consult a healthcare professional before supplementation, due to a possible additive effect on blood sugar or lipids. Supplementation is not recommended during pregnancy and breastfeeding, given insufficient safety data in these populations. In children, use is also not recommended due to the lack of specific data.
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Yin J et al. | 2008 | Randomised Controlled Trial | Metabolism | View on PubMed |
Efficacy of berberine in patients with type 2 diabetes mellitus Randomized controlled trial showing berberine significantly reduces fasting blood glucose and glycated hemoglobin in participants with disrupted carbohydrate metabolism, with efficacy comparable to metformin. | ||||
| Dong H et al. | 2013 | Meta-analysis | Planta Medica | View on PubMed |
The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials Meta-analysis of 11 randomized trials confirming a significant reduction in total cholesterol, LDL, and triglycerides with berberine supplementation. | ||||
| Lan J et al. | 2015 | Meta-analysis | Journal of Ethnopharmacology | View on PubMed |
Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension Meta-analysis evaluating the effects of berberine on cardiovascular and metabolic parameters, including blood glucose, lipids, and blood pressure. | ||||
| Ju J et al. | 2018 | Meta-analysis | Phytomedicine | View on PubMed |
Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials Meta-analysis of 16 randomized trials involving over 2,000 participants, confirming berberine efficacy and safety on lipid profiles. | ||||
| Zhang L et al. | 2020 | Systematic Review | Frontiers in Cellular and Infection Microbiology | View on PubMed |
Effects of Berberine on the Gastrointestinal Microbiota Systematic review exploring berberine effects on gut microbiota composition and implications for metabolism. | ||||
| Asbaghi O et al. | 2020 | Meta-analysis | Clinical Nutrition ESPEN | View on PubMed |
The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials Meta-analysis of 12 controlled trials showing a favorable effect of berberine on body weight, BMI, and waist circumference. | ||||
| Kong WJ et al. | 2020 | Systematic Review | Pharmacology and Therapeutics | View on PubMed |
Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders Comprehensive review of berberine mechanisms of action on energy metabolism and cellular signaling pathways involved in aging. | ||||